CLINICAL_TRIALS
trial_result
· 2010-03-11
Clinical Trial Update: Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 trial of adalimumab in active ankylosing spondylitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2010-03-11